cccDNA
生物
病毒学
乙型肝炎病毒
癌症研究
报告基因
HBx公司
分子生物学
HEK 293细胞
遗传学
细胞培养
乙型肝炎
肝癌
作者
Jiali Cao,Yali Zhang,Jian Ma,Shaojuan Wang,Yangtao Wu,Hualong Xiong,Mingfeng Wang,Tianshu Shi,Baorong Fu,Xiaochun Fu,Xiaoli Chen,Huiming Ye,Ningshao Xia,Quan Yuan
出处
期刊:Virulence
[Taylor & Francis]
日期:2026-09-04
卷期号:17 (1): 2728526-2728526
标识
DOI:10.1080/21505594.2026.2728526
摘要
Chronic hepatitis B remains difficult to cure because the viral covalently closed circular DNA (cccDNA) minichromosome can persist and sustain viral transcription, creating a need for scalable, reporter readouts that facilitate early discovery of cccDNA-modulating agents. Here, we developed two complementary hepatocyte HiBiT reporter models: a replication-competent HBV reporter in HepaRG cells (HepaRG-Hibit16), in which a secreted split-NanoLuc HiBiT signal is linked to cccDNA-associated expression, and a Cre/Lox-based recombinant cccDNA (rcccDNA) reporter in HepG2 cells (HepG2-Rccc1a) that rapidly generates rcccDNA with a matched HiBiT readout. Screening of 1,403 FDA-approved compounds across both models identified 13 concordant, non-cytotoxic hits. Palovarotene, a retinoic acid receptor-γ agonist, was selected as an exemplar concordant hit and reduced HBV antigens, HBV DNA, and cccDNA and inhibited HBV infection in multiple hepatocyte-based in vitro systems without overt cytotoxicity at the tested concentrations. Together, this dual-reporter strategy supports efficient cross-model triage of candidate cccDNA modulators for subsequent orthogonal validation.
科研通智能强力驱动
Strongly Powered by AbleSci AI